Cargando…

First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient

Detalles Bibliográficos
Autores principales:	Fordham, Nicholas, Baker, Emma, Forton, Daniel, Klammer, Matthias, Patel, Kamal, Qadir, Dara, Reyal, Yasmin, Willis, Fenella, Koh, Mickey B.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175733/ https://www.ncbi.nlm.nih.gov/pubmed/35846103 http://dx.doi.org/10.1002/jha2.132

Ejemplares similares

Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021)

O03 A case of hyperinflammatory COVID-19 that responded to tocilizumab therapy
por: Biddle, Kathryn, et al.
Publicado: (2020)

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort()
por: Corominas, Hèctor, et al.
Publicado: (2021)

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

Drugs for paediatric hyperinflammatory syndromes
por: Hon, Kam Lun, et al.
Publicado: (2022)

The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control
por: Planas, Raquel, et al.
Publicado: (2023)

Haemophagocytic lymphohisticytosis—an underrecognized hyperinflammatory syndrome
por: Hutchinson, Matthew, et al.
Publicado: (2019)

Infection-Triggered Hyperinflammatory Syndromes in Children
por: Rossano, Martina, et al.
Publicado: (2022)

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
por: Toniati, Paola, et al.
Publicado: (2020)

Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections
por: Minihan, B., et al.
Publicado: (2022)

Hyperinflammatory shock in children during COVID-19 pandemic
por: Riphagen, Shelley, et al.
Publicado: (2020)

Hyperinflammatory Response in COVID-19: A Systematic Review
por: Silva, Marcos Jessé Abrahão, et al.
Publicado: (2023)

Drug‐resistant seizures associated with hyperinflammatory monocytes in FIRES
por: Howe, Charles L., et al.
Publicado: (2023)

Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
por: Demouche, Sarah, et al.
Publicado: (2022)

Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19
por: Koh, June-Young, et al.
Publicado: (2023)

Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels’ Score Lesions and Impending Pathological Hip Fracture
por: Divekar, Omkaar, et al.
Publicado: (2023)

Dynamics of Inflammatory Response in Autoinflammatory Disorders: Autonomous and Hyperinflammatory States
por: Gül, Ahmet
Publicado: (2018)

Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness
por: Bhat, Chandrika S., et al.
Publicado: (2020)

Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
por: Vitiello, Antonio, et al.
Publicado: (2021)

Defining COVID-19-associated hyperinflammatory syndrome in specific populations
por: Webb, Brandon J
Publicado: (2021)

The Techniques of Blood Purification in the Treatment of Sepsis and Other Hyperinflammatory Conditions
por: Berlot, Giorgio, et al.
Publicado: (2023)

Eosinophilic pulmonary vasculitis as a manifestation of the hyperinflammatory phase of COVID-19
por: Luecke, Eva, et al.
Publicado: (2021)

Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
por: Sims, Jonathan T., et al.
Publicado: (2021)

COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes
por: Hobbs, Charlotte V., et al.
Publicado: (2020)

Aortic thrombosis in a patient with COVID-19-associated hyperinflammatory syndrome
por: Michotte, Naomi, et al.
Publicado: (2021)

Still’s Disease in the Constellation of Hyperinflammatory Syndromes: A Link with Kawasaki Disease?
por: Dusser, Perrine, et al.
Publicado: (2021)

The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock
por: Hawchar, Fatime, et al.
Publicado: (2021)

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
por: Tan, Li Yin, et al.
Publicado: (2021)

Post-Infectious COVID-19-Associated Hyperinflammatory Syndrome in An Older Patient
por: Famularo, Giuseppe, et al.
Publicado: (2022)

How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19
por: Müller, Ludmila, et al.
Publicado: (2021)

Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells
por: Barro, Lassina, et al.
Publicado: (2020)

EP10 Hyperinflammatory syndrome in a patient with rheumatoid arthritis and COVID-19
por: Ong, Melissa, et al.
Publicado: (2020)

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
por: Funk, Colin D., et al.
Publicado: (2020)

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
por: Webb, Brandon J, et al.
Publicado: (2020)

Does Helium Pneumoperitoneum Reduce the Hyperinflammatory Response in Septic Animals during Laparoscopy?
por: Roberto Rodrigues Bicalho, Paulo, et al.
Publicado: (2020)

Modern Beijing sublineage of Mycobacterium tuberculosis shift macrophage into a hyperinflammatory status
por: Tong, Jingfeng, et al.
Publicado: (2022)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Safe use of tocilizumab in pregnant women with Takayasu arteritis: three case studies
por: Konagai, Nao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2mt2hdkchi8oaai980hhut5sra